HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effect of Telmisartan on local cardiovascular oxidative stress in mouse under chronic intermittent hypoxia condition.

AbstractOBJECTIVE:
The objective of this study is to explore the protective effect of an angiotensin receptor blocker (ARB) on local cardiovascular angiotensin II (AngII) and oxidative stress markers such as malondialdehyde (MDA), NADPH oxydase p47(phox), and 8-hydroxy-2'-deoxyguanosine/8-hydroxyguanosine (8-OHdG/8-OHG) of mice that had chronic intermittent hypoxia (CIH).
METHODS:
Thirty-two healthy male C57B6J mice were randomly divided into four groups: CIH (12 weeks of CIH), ARB (CIH+Telmisartan), air control (room air delivery), and blank control (no treatment). AngII, p47(phox), and 8-OHdG/8-OHG were detected in mouse cardiocytes by immunohistochemistry. MDA was measured with the thiobarbituric acid method.
MEASUREMENTS AND RESULTS:
The highest AngII levels occur in the ARB treatment group (P < 0.05), followed by the CIH group (which was higher than the two control groups; P = 0.000). The levels of p47(phox) were statistically higher in the CIH group than in the other groups (P = 0.000) and lower in the ARB group (but still higher than in the two control groups, P = 0.000). The levels of 8-OHdG/8-OHG were the highest in the CIH group (P < 0.05), followed by the ARB group (which was higher than the two control groups, P = 0.000). The levels of MDA in the myocardial homogenate of mice were the highest in the CIH group (P = 0.000).
CONCLUSIONS:
Based on the above results, it can be concluded that Telmisartan may protect mouse cardiocytes from oxidative stress damage due to CIH.
AuthorsWan-Yu Wang, Wan-Yu Wan, Yi-Ming Zeng, Xiao-Yang Chen, Yi-Xiang Zhang
JournalSleep & breathing = Schlaf & Atmung (Sleep Breath) Vol. 17 Issue 1 Pg. 181-7 (Mar 2013) ISSN: 1522-1709 [Electronic] Germany
PMID22447170 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Angiotensin II Type 1 Receptor Blockers
  • Benzimidazoles
  • Benzoates
  • Biomarkers
  • NADPH Oxidases
  • Telmisartan
Topics
  • Administration, Oral
  • Angiotensin II Type 1 Receptor Blockers (pharmacology)
  • Animals
  • Benzimidazoles (pharmacology)
  • Benzoates (pharmacology)
  • Biomarkers (analysis)
  • Chronic Disease
  • Disease Models, Animal
  • Hypoxia (physiopathology)
  • Male
  • Mice
  • Mice, Inbred Strains
  • Myocardium (pathology)
  • NADPH Oxidases (physiology)
  • Oxidative Stress (drug effects, physiology)
  • Reference Values
  • Sleep Apnea, Obstructive (physiopathology)
  • Telmisartan

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: